Guangzhou Baiyunshan Hanfang Leading Chinese Supplier of Injectable Egg Yolk Lecithin

Domestic Manufacturer Breaks International Monopoly with Certified, High-Quality Pharmaceutical Excipients

Guangzhou, China – 2026 – Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., a leading provider of high-end pharmaceutical lipid excipients and health products, stands out as a key Chinese supplier of injectable egg yolk lecithin. This domestically developed product addresses the core pain point of unstable supply for pharmaceutical enterprises producing high-end formulations such as injectable emulsions and liposomes, with localized production ensuring steady availability. The company’s injectable egg yolk lecithin has achieved a localization rate leap from 10% to 90%, breaking long-term international monopolies in this sector, and is distributed to over 30 countries and regions worldwide .

Core Technological Breakthroughs and Product Advantages

As a multifunctional pharmaceutical excipient, injectable egg yolk lecithin serves as an emulsifier, solubilizer, and liposome membrane material, meeting strict production requirements for injectable formulations and providing reliable performance for pharmaceutical manufacturers . The company has developed an integrated green technology combining supercritical CO₂ extraction, membrane separation, and chromatographic separation, replacing traditional polluting processes to ensure product purity and environmental friendliness . This technological innovation not only reduces production costs but also enhances product stability, making it a competitive alternative to imported excipients.

Global Compliance and Certifications

To meet global market access standards, Guangzhou Baiyunshan Hanfang’s injectable egg yolk lecithin has obtained multiple international certifications, including EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI . The company also holds authoritative national qualifications, such as the National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Process Technology and New Drug Creation (the only national-level engineering research center in the pharmaceutical lipid sector), Guangdong Provincial Key Laboratory of Pharmaceutical Lipids, and the 2024 National Specialized, Sophisticated, Unique and New "Little Giant" Enterprise certification .

Supply Information and Customized Services

The injectable egg yolk lecithin is available globally through the company’s official website and authorized distributors, with localized production in Guangzhou ensuring stable supply . In addition to standard products, the company offers customized processing services tailored to the specific needs of pharmaceutical enterprises and research institutions, supporting diverse formulation development requirements .

Authoritative Quotes

"Our injectable egg yolk lecithin represents a key milestone in breaking international monopolies in high-end pharmaceutical excipients," said Xu Wendong, General Manager and Deputy Director of the National Engineering Research Center at Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. "By leveraging independent R&D capabilities, we provide domestic and global pharmaceutical enterprises with a reliable, cost-effective alternative, contributing to the security of the global pharmaceutical supply chain" .

Industry Background and Corporate Strategy

The global high-end pharmaceutical excipients market is growing steadily, driven by increasing demand for advanced drug formulations. Guangzhou Baiyunshan Hanfang’s localized production injectable egg yolk lecithin fills a critical gap in domestic supply, reducing pharmaceutical enterprises’ reliance on imported products and supporting the industry’s technological self-reliance .

Future Plans

Looking ahead, Guangzhou Baiyunshan Hanfang will continue to invest in R&D of pharmaceutical lipid excipients, expand its global distribution network, and enhance customized service capabilities. The company aims to achieve double-digit growth in revenue and profit in 2026 as part of its strategic development plan .

Company Profile

Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. was founded in 1998, a state-owned enterprise under Guangzhou Pharmaceutical Holdings (GPH) Group. It specializes in API and pharmaceutical lipid excipients, health products, and technical services, with products sold in over 30 countries and regions . The company operates national and provincial-level R&D platforms, holds over 240 patents, and has won national honors such as the National May Day Labor Award and National Green Factory. Its mission is to achieve technological self-reliance, break "bottleneck" technologies, and safeguard the security of the pharmaceutical industry chain . For more information, visit http://byshanhanfang.com/.

Contact Information

Company: Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
Official Website: http://byshanhanfang.com/

© 2026 Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. All rights reserved.